Biogen (BIIB) Raw Materials (2010 - 2018)
Biogen (BIIB) recorded quarterly Raw Materials of $196.3 million in Q4 2018, up 20.87% quarter-over-quarter from $162.4 million in Q4 2017, and up 20.87% on a YoY basis from $162.4 million in Q4 2017.
Biogen (BIIB) Raw Materials (2010 - 2018) Analysis & Trends
Biogen's Raw Materials history runs 9 years deep, the most recent figure standing at $196.3 million for Q4 2018.
- In Q4 2018, Raw Materials rose 20.87% year-over-year to $196.3 million; the TTM figure through Dec 2018 stood at $196.3 million (up 20.87% YoY), while the FY2018 annual figure was $196.3 million, up 20.87% from the prior year.
- Raw Materials was $196.3 million for Q4 2018 at Biogen, up from $162.4 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $213.0 million in Q4 2015 to a low of $128.3 million in Q4 2014.
- Historically, Raw Materials has averaged $174.1 million across 5 years, with a median of $170.4 million in 2016.
- The sharpest annual moves came in 2015 and 2016: Raw Materials jumped 66.02% in 2015, then declined 20.0% in 2016.
- A 5-year view of Raw Materials shows it stood at $128.3 million in 2014, then surged by 66.02% to $213.0 million in 2015, then dropped by 20.0% to $170.4 million in 2016, then declined by 4.69% to $162.4 million in 2017, then advanced by 20.87% to $196.3 million in 2018.
- The last three Raw Materials figures came in at $196.3 million (Q4 2018), $162.4 million (Q4 2017), and $170.4 million (Q4 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Biogen | 28.75 Bn | 24.47 Bn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 196.30 Mn |
| Dec 31, 2017 | 162.40 Mn |
| Dec 31, 2016 | 170.40 Mn |
| Dec 31, 2015 | 213.00 Mn |
| Dec 31, 2014 | 128.30 Mn |
| Dec 31, 2013 | 115.00 Mn |
| Mar 31, 2013 | 109.80 Mn |
| Dec 31, 2012 | 101.80 Mn |
| Jun 30, 2012 | 92.90 Mn |
| Mar 31, 2012 | 90.80 Mn |
| Dec 31, 2011 | 83.80 Mn |
| Dec 31, 2010 | 59.00 Mn |